Ticker Scorecard - BPMC Basics Company: Blueprint Medicines Corporation IPO Date: May 1, 2015 Sector: Healthcare Industry: Biotech Market Cap: $7.1B Activated in VL: True Average Daily Range Avg Daily Range: $1.46 | 2.38% Avg Daily Range (30 D): $2.10 | 2.16% Avg Daily Range (90 D): $1.68 | 1.78% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .67M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 5,866 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $6.27M Avg Inst. Trade (90 D): $5.21M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $5.16M Avg Closing Trade (30 D): $11.67M Avg Closing Trade (90 D): $10.14M Avg Closing Volume: 70.19K     News Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Jun 28, 2024 @ 1:00 PM Expert Ratings For Blueprint Medicines Source: Benzinga Insights Jun 7, 2024 @ 6:01 PM Assessing Blueprint Medicines: Insights From 16 Fi... Source: Benzinga Insights May 14, 2024 @ 4:00 PM Unveiling 18 Analyst Insights On Blueprint Medicin... Source: Benzinga Insights May 7, 2024 @ 10:40 AM Zacks Industry Outlook Highlights BioMarin, Bluepr... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.09 $-.89 $-.8 Diluted EPS $-2.11 $-.89 $-.8 Revenue $ 434.41M $ 128.18M $ 138.16M Gross Profit $ 421.44M $ 126.25M $ 130.56M Net Income / Loss $ -128.05M $ -56.28M $ -49.99M Operating Income / Loss $ -275.95M $ -48.97M $ -43.05M Cost of Revenue $ 12.98M $ 1.93M $ 7.59M Net Cash Flow $ 34.29M $ 34.69M $ -58.35M PE Ratio